Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 10 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact10 DOIs

DOIs for this ISSN

Showing the top 5 of 129 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Ketamine and Esketamine in Psychiatry: A Comparative Review… (10.3390/psychoactives4030020)	ORCID	22.58	7
2	The Key Role of Intracellular 5-HT2A Receptors: A Turning Po… (10.3390/psychoactives2040018)	ORCID	21.13	6
3	Unlocking the Potential of Meldonium: From Performance Enhan… (10.3390/psychoactives3020015)	ORCID	21.13	6
4	Use of Methylphenidate for Hypoactive Delirium: A Comprehens… (10.3390/psychoactives2040021)	ORCID	15.05	3
5	Disparities in Substance Co-Use among Sexual Minority and He… (10.3390/psychoactives3010008)	ORCID	11.93	2
6	Rapid and Prolonged Antidepressant and Antianxiety Effects o… (10.3390/psychoactives3040029)	ORCID	11.93	2
7	Hormonal Influences on Psilocybin Responsivity Across the Fe… (10.3390/psychoactives4040039)	ORCID	11.93	2
8	From Adults to Adolescents: Bridging Scientific Potential an… (10.3390/psychoactives5010002)	ORCID	7.53	1
9	The Genesis of a New Open-Access Journal Focused on the Late… (10.3390/psychoactives1010001)		0.00	3
10	Driving under the Influence of Psychotropic Substances: A Te… (10.3390/psychoactives1010002)		0.00	5
11	Tripping to Cope: Coping Strategies and Use of Hallucinogens… (10.3390/psychoactives1010003)		0.00	9
12	Parental Perceptions of the Efficacy of Methylphenidate on H… (10.3390/psychoactives1010004)		0.00	2
13	Publisher’s Note: Psychoactives, a New Open Access Journal (10.3390/psychoactives1010005)		0.00	0
14	The Role of the Dynorphin/Kappa Opioid Receptor System in th… (10.3390/psychoactives1020006)		0.00	5
15	Genotoxic Aspects of Psychoactive Substances (10.3390/psychoactives1020007)		0.00	1
16	The Nose Knows: Aroma, but Not THC Mediates the Subjective E… (10.3390/psychoactives1020008)		0.00	13
17	Natural Hallucinogens in Mental Health (10.3390/psychoactives1020009)		0.00	0
18	Concurrent Hookah (Waterpipe) and Substance Use among Sexual… (10.3390/psychoactives1020010)		0.00	3
19	In Silico Infrared Spectroscopy as a Benchmark for Identifyi… (10.3390/psychoactives2010001)		0.00	5
20	Factors Associated with Changes in E-Cigarette Use and Tobac… (10.3390/psychoactives2010002)		0.00	9
21	A Review on the Impact of Cannabis in Society and the Analyt… (10.3390/psychoactives2010003)		0.00	5
22	Cannabis and Palliative Care Utilization among Non-Terminal… (10.3390/psychoactives2010004)		0.00	1
23	Does Cannabidiol (CBD) in Food Supplements Pose a Serious He… (10.3390/psychoactives2010005)		0.00	28
24	Neural Network Modulation of Ayahuasca: A Systematic Review… (10.3390/psychoactives2010006)		0.00	5
25	Application of Drug Efficiency Index Metric for Analysis of… (10.3390/psychoactives2020007)		0.00	6
26	Social Jeopardy of Substance Use among Adolescents: A Review… (10.3390/psychoactives2020008)		0.00	6
27	Substance Use and Its Association with Risky Sexual Behaviou… (10.3390/psychoactives2020009)		0.00	2
28	Substance Use and Housing Stability among Individuals Experi… (10.3390/psychoactives2020010)		0.00	6
29	Considerations in the Application of Psychedelic-Augmented P… (10.3390/psychoactives2020011)		0.00	2
30	Transpersonal Ecodelia: Surveying Psychedelically Induced Bi… (10.3390/psychoactives2020012)		0.00	17
31	Supervenience and the Public Health Standard for Psychoactiv… (10.3390/psychoactives2020013)		0.00	0
32	Life after Ayahuasca: A Qualitative Analysis of the Psychede… (10.3390/psychoactives2020014)		0.00	18
33	Pharmacokinetic and Toxicological Aspects of 1,3-Dimethylamy… (10.3390/psychoactives2030015)		0.00	3
34	A Comprehensive Analysis of Legislative Strategies for New P… (10.3390/psychoactives2030016)		0.00	9
35	Insights, Life Changes and Lifestyle Changes Reported by Ind… (10.3390/psychoactives2040017)		0.00	17
36	Towards a New Dynamic Interaction Model of Adolescent CUD Ma… (10.3390/psychoactives2040019)		0.00	3
37	The Imperative of Regulation: The Co-Creation of a Medical a… (10.3390/psychoactives2040020)		0.00	7
38	Subjective Effects of a Single Dose of Ayahuasca among Colle… (10.3390/psychoactives2040022)		0.00	4
39	Voltammetric MDMA Analysis of Seized Ecstasy Samples (10.3390/psychoactives2040023)		0.00	6
40	Guidelines for Establishing Safety in Ayahuasca and Ibogaine… (10.3390/psychoactives2040024)		0.00	3
41	The Noscapine Saga: Unravelling a Valuable Jewel from a Popp… (10.3390/psychoactives3010001)		0.00	5
42	Psychotropic Medications and Dermatological Side Effects: An… (10.3390/psychoactives3010002)		0.00	4
43	Neurobiological Theories of Addiction: A Comprehensive Revie… (10.3390/psychoactives3010003)		0.00	24
44	The Effects of Psilocybin on Lipopolysaccharide-Induced Infl… (10.3390/psychoactives3010004)		0.00	13
45	Work Stress and Psychoactive Substance Use among Correctiona… (10.3390/psychoactives3010005)		0.00	1
46	Does Conformation Affect the Analytical Response? A Structur… (10.3390/psychoactives3010006)		0.00	3
47	The Clinical Potential of Dimethyltryptamine: Breakthroughs… (10.3390/psychoactives3010007)		0.00	8
48	New Choking Epidemic Trends in Psychoactive Drugs: The Zombi… (10.3390/psychoactives3010009)		0.00	4
49	Producing Altered States of Consciousness, Reducing Substanc… (10.3390/psychoactives3020010)		0.00	1
50	Self-Rated Effectiveness of Ayahuasca and Breathwork on Well… (10.3390/psychoactives3020011)		0.00	3